In the United States, about 20% of patients are readmitted to the hospital within thirty days of their discharge, and 7% of patients are readmitted within seven days. Patient readmissions are strenuous on the health of the patient and extremely costly.
The average patient costs the healthcare industry $21,156 of treatment when suffering with a compilation. This is compared to $10,978 when they do not suffer from any post-operative complications; resulting in potential savings of $10,178.
Statistics have shown that preventable illness represents 80% of the burden to providers and 90% of all healthcare costs. Using NERv’s biochip, NERv promises that it can reduce the costs associated with doing routine, unnecessary investigations that are mainly done as a precautionary measure.
NERv’s Solution guarantees approximately a 33% reduction in costs by removing costs associated with the late detection of post-operative complications and the unnecessary routine investigations.